Generic diabetes drug put to the test against Brand-Name synjardy
NCT ID NCT07266766
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study checked whether a generic version of the diabetes drug empagliflozin/metformin works the same as the brand-name Synjardy XR. Forty healthy adults took a single dose of each pill under fed conditions. The goal was to see if the generic matches the brand in how much drug gets into the blood. This helps ensure patients can get a lower-cost option that works just as well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Veeda Clinical Research Limited
Ahmedabad, Gujarat, 384205, India
Conditions
Explore the condition pages connected to this study.